Atrial arrhythmia

Disease1 paper1 finding

Interventions

1

Tirzepatide

no changein humans1OR 2.16

1 study

Tirzepatide has no effect on atrial arrhythmia in humans (OR 2.16, 95% CrI 0.90-5.87).
Human trialoverweight or obesity
Tirzepatide and the Incidence of Atrial Fibrillation in Adults With Overweight or Obesity: An Updated Meta-Analysis of Randomized Controlled Trials · Journal of the American Heart Association · 9 Sep 2026

Tirzepatide →

Latest

5

Current Cardiology ReviewsReview21 Sep

Beyond Glycemic Control: Multi-pathway Cardioprotective Mechanisms of Selective Na+/glucose Co-transporter 2 Inhibitors with Emerging Implications for Atrial Fibrillation

SGLT2 inhibitors

Journal of the American Heart AssociationReview9 Sep

Tirzepatide and the Incidence of Atrial Fibrillation in Adults With Overweight or Obesity: An Updated Meta-Analysis of Randomized Controlled Trials

JACC Clinical ElectrophysiologyHuman trial28 Aug

Metformin as an Adjunctive Therapy to Catheter Ablation of Atrial Fibrillation (META-AF)

AHA Scientific Sessions 2025 AbstractHumans3 Nov

Rates of Atrial Fibrillation and Atrial Flutter in Non-diabetic Obese Adult Patients on Tirzepatide

AHA Scientific Sessions 2025 AbstractHumans3 Nov

Glucagon-Like Peptide-1 Receptor Agonists with Guideline Therapy Lower Mortality and Hospitalizations in HFpEF: A Propensity-Matched U.S. TriNetX Study